Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2014-03-06 Major Shareholding Noti…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20140306 - Transparentieverklaring van Vanguard.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled "Transparantieverklaring van Vanguard Health Care Fund" (Transparency Declaration of Vanguard Health Care Fund) and explicitly references compliance with the Belgian law of May 2, 2007, regarding the disclosure of major shareholdings ('openbaarmaking van belangrijke deelnemingen'). It details that Vanguard Health Care Fund's stake in UCB NV has fallen below the 5% threshold due to a capital increase. This type of filing, which reports changes in significant share ownership by an entity, directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is presented as a press release, the core content is the notification of a change in ownership percentage crossing a regulatory threshold.
2014-03-06 Dutch
2013 annual report_ENG_interactive.pdf
Annual Report Classification · 100% confidence The document is a comprehensive annual report for UCB, containing a letter to stakeholders, management reports, consolidated financial statements, notes to the financial statements, and a review of business performance. It covers the full fiscal year 2013 and provides detailed financial tables and strategic outlooks. It is clearly the primary annual report document, not an announcement or a summary. FY 2013
2014-02-26 English
UCB_RA_2013_FR.pdf
Annual Report Classification · 100% confidence The document is a comprehensive annual report for UCB, containing a letter to stakeholders, management reports, financial statements, notes to financial statements, and performance metrics for the fiscal year 2013. It is clearly a full annual report rather than an announcement or a summary, as it includes detailed financial tables, operational reviews, and governance information. FY 2013
2014-02-26 French
UCB_RA_2013_NL.pdf
Annual Report Classification · 100% confidence The document is a comprehensive annual report for UCB, containing a letter to stakeholders, management reports, consolidated financial statements, and detailed business performance analysis for the fiscal year 2013. It is clearly a full annual report rather than an announcement or a summary, as it includes detailed financial tables, pipeline progress, and strategic priorities. FY 2013
2014-02-26 Dutch
UCB FY Results 2013 EN.pdf
Earnings Release Classification · 100% confidence The document is an initial announcement of annual financial results for the year 2013, released on February 26, 2014. It contains key financial highlights, revenue figures, EBITDA, and EPS, but explicitly states that the 'full financial report' is available on the company website, providing a link. This confirms it is an earnings release (summary) rather than the full annual report itself. It follows the standard format of an Earnings Release (ER) by providing highlights, management commentary, and a summary table of financial performance. FY 2013
2014-02-26 English
UCB FY Results 2013 FR.pdf
Earnings Release Classification · 95% confidence The document is an initial announcement of annual financial results (2013) for UCB. It provides key financial highlights, EBITDA, net income, dividend proposals, and R&D updates. While it contains substantive financial data, it is structured as a press release (dated, location, quotes from CEO) and explicitly directs the reader to the full annual report on their website, confirming it is an Earnings Release rather than the full Annual Report itself. FY 2013
2014-02-26 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.